[Renal lymphoma in a transplanted patient treated with cyclosporine].
The effectiveness of renal transplantation has been considerably improved by the use of cyclosporine as an antirejection agent. However, because of those very same immunosuppressive properties, this substance may lead to several infectious or tumoral complications that raise complex therapeutic problems. This article reports about one case of immunoblastic lymphoma discovered in a patient who received renal transplantation and who had been treated with cyclosporine for two years.
Service de Radiologie Centrale, Hôpital de La Pitié, Paris.
G
G
Drahy
E
E
Dion
C
C
Faucher
M F
MF
Bellin
D016572:Cyclosporine / Q000009:adverse effects*; D006084:Graft Rejection; D006801:Humans; D007676:Kidney Failure, Chronic / Q000601:surgery; D007680:Kidney Neoplasms / Q000139:chemically induced / Q000209:etiology*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000139:chemically induced / Q000209:etiology*; D014057:Tomography, X-Ray Computed
D016572:Cyclosporine
Lymphome rénal chez un transplanté traité par ciclosporine.